
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings is positioned for strong growth in the future, supported by their positive performance in the core spinal surgery business and the launch of new products such as Valence and OsteoAdapt. Despite missing consensus revenue in the first quarter due to weakness in EOS, the company's continued growth in surgical case volume and surgeon addition bodes well for future procedure volumes and revenue growth. Furthermore, the company's strong margin performance and ability to exceed expectations in gross margin and operating margin demonstrate the potential for continued improvement in their balance sheet and leverage position. Overall, the positive outlook for Alphatec Holdings is supported by their strong fundamentals and potential for future growth.
Bears say
Alphatec Holdings is facing risks to their revenue growth due to poor sales execution and increased competition in the spine market. Additionally, potential dilution from equity offerings and acquisitions could negatively impact their profitability. Furthermore, the recent earnings report showed a disappointing quarter for their EOS franchise, which led to a reduction in full-year revenue expectations. However, the underlying market remains healthy and the company is taking steps to address their execution challenges. Ultimately, the recent pullback in the stock price is seen as an overreaction, but there are still potential risks to the target price of $14.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares